markets

Rep. David Taylor Buys Amgen, Home Depot; Dumps Marathon Petroleum

Summarized from Investing.com

Congressman David J. Taylor traded three major stocks on Sept. 22, 2026, disclosing the moves nine days later per federal reporting rules.

Rep. David Taylor Buys Amgen, Home Depot; Dumps Marathon Petroleum

Congressman David J. Taylor reshuffled his personal stock holdings on September 22, 2026, acquiring shares in biopharmaceutical giant Amgen Inc. and home-improvement retailer Home Depot, Inc. while simultaneously exiting his position in Marathon Petroleum Corporation. The transactions were publicly disclosed on October 1, 2026, consistent with the federal requirement that lawmakers report trades within 45 days.

Each of the three trades carried a reported value between $1,001 and $15,000, the lowest disclosure bracket required under the STOCK Act, meaning the precise dollar amounts remain undisclosed. The clustered execution date suggests a deliberate single-day rebalancing rather than a gradual shift in strategy.

Read more HCAC and REEcycle File S-4 With SEC for Planned Merger →

Amgen drew particular attention among the purchases. The Thousand Oaks, California-based drugmaker has raised its dividend for 15 consecutive years and is characterized by InvestingPro analysis as undervalued, a combination that tends to attract income-focused investors seeking defensive positioning. Home Depot, meanwhile, offers broad exposure to consumer spending on housing maintenance and renovation.

The sale of Marathon Petroleum signals a reduced appetite for energy-sector exposure, at least at the margin. Whether the move reflects a broader view on oil refining margins or simply portfolio housekeeping is not clear from the disclosure alone. Congressional stock trades continue to draw scrutiny from ethics watchdogs and the public, given lawmakers' potential access to non-public legislative information.

Continue reading at Investing.com

Frequently Asked Questions

Q.When did Congressman David Taylor make these stock trades?

All three transactions were executed on September 22, 2026, and reported to the public on October 1, 2026.

Q.How much money did David Taylor invest in Amgen and Home Depot?

Each transaction was valued between $1,001 and $15,000, the minimum disclosure bracket under the STOCK Act, so exact figures are not public.

Q.Why is Amgen considered a notable buy for investors?

According to InvestingPro analysis cited in the disclosure reporting, Amgen is considered undervalued and has raised its dividend for 15 consecutive years, making it attractive for income-focused investors.

More in markets →